Published in Int J Parasitol on December 01, 2004
Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci U S A (2005) 2.71
Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev (2013) 2.36
Plasmodium vivax: who cares? Malar J (2008) 1.98
The anaemia of Plasmodium vivax malaria. Malar J (2012) 1.82
Increased expression levels of the pvcrt-o and pvmdr1 genes in a patient with severe Plasmodium vivax malaria. Malar J (2009) 1.26
Sequestration and tissue accumulation of human malaria parasites: can we learn anything from rodent models of malaria? PLoS Pathog (2010) 1.23
Host control of malaria infections: constraints on immune and erythropoeitic response kinetics. PLoS Comput Biol (2008) 1.05
Characterization and gene expression analysis of the cir multi-gene family of Plasmodium chabaudi chabaudi (AS). BMC Genomics (2012) 0.99
Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria. PLoS Pathog (2015) 0.98
Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Infect Immun (2006) 0.97
Characterization and tissue-specific expression patterns of the Plasmodium chabaudi cir multigene family. Malar J (2011) 0.96
Evaluation of the acquired immune responses to Plasmodium vivax VIR variant antigens in individuals living in malaria-endemic areas of Brazil. Malar J (2006) 0.90
Determination of the Plasmodium vivax schizont stage proteome. J Proteomics (2011) 0.90
Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites. Infect Immun (2005) 0.89
Rapid changes in transcription profiles of the Plasmodium yoelii yir multigene family in clonal populations: lack of epigenetic memory? PLoS One (2009) 0.88
Population dynamics of a pathogen: the conundrum of vivax malaria. Biophys Rev (2010) 0.86
Potential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling question. Infect Immun (2014) 0.86
Acute pancreatitis, ascites, and acute renal failure in Plasmodium vivax malaria infection, a rare complication. Trop Parasitol (2015) 0.83
Core genome components and lineage specific expansions in malaria parasites plasmodium. BMC Genomics (2010) 0.82
Comparative Genomics and Systems Biology of Malaria Parasites Plasmodium. Curr Bioinform (2012) 0.75
Diversity of vir Genes in Plasmodium vivax from Endemic Regions in the Republic of Korea: an Initial Evaluation. Korean J Parasitol (2017) 0.75
In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity (2002) 14.57
Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature (2008) 5.96
The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature (2006) 3.31
CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat Med (2007) 2.79
Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis (2012) 2.53
A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep (2005) 2.53
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med (2006) 2.43
Polymorphisms within PfMDR1 alter the substrate specificity for anti-malarial drugs in Plasmodium falciparum. Mol Microbiol (2008) 2.21
Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett (2011) 2.00
IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nat Med (2002) 1.86
Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes. Science (2011) 1.66
Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol Rev (2008) 1.64
Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J (2006) 1.58
Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice. Vaccine (2010) 1.54
Trafficking of STEVOR to the Maurer's clefts in Plasmodium falciparum-infected erythrocytes. EMBO J (2005) 1.50
T cells as mediators of protective immunity against liver stages of Plasmodium. Trends Parasitol (2003) 1.45
Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites. PLoS Pathog (2010) 1.39
Transporters as mediators of drug resistance in Plasmodium falciparum. Int J Parasitol (2010) 1.36
Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe (2008) 1.34
IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites. J Exp Med (2005) 1.31
Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains. Biochemistry (2004) 1.28
Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo. PLoS Pathog (2011) 1.27
A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1. Infect Immun (2006) 1.27
Expression and function of pvcrt-o, a Plasmodium vivax ortholog of pfcrt, in Plasmodium falciparum and Dictyostelium discoideum. Mol Biochem Parasitol (2006) 1.25
Neuropathogenesis of human and murine malaria. Trends Parasitol (2010) 1.24
Trans stimulation provides evidence for a drug efflux carrier as the mechanism of chloroquine resistance in Plasmodium falciparum. Biochemistry (2003) 1.24
Effector and memory CD8+ T cells as seen in immunity to malaria. Immunol Rev (2004) 1.22
A global view of the nonprotein-coding transcriptome in Plasmodium falciparum. Nucleic Acids Res (2009) 1.21
Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry (2005) 1.20
Looking under the skin: the first steps in malarial infection and immunity. Nat Rev Microbiol (2013) 1.20
Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin. Cell Microbiol (2007) 1.16
Paucity of Plasmodium vivax mature schizonts in peripheral blood is associated with their increased cytoadhesive potential. J Infect Dis (2014) 1.13
Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum. Trends Parasitol (2007) 1.10
Viral vectors for malaria vaccine development. Vaccine (2006) 1.10
In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages. Proc Natl Acad Sci U S A (2013) 1.10
Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages. Proc Natl Acad Sci U S A (2002) 1.10
Multi-character population study of the vir subtelomeric multigene superfamily of Plasmodium vivax, a major human malaria parasite. Mol Biochem Parasitol (2006) 1.08
Evidence for trafficking of PfEMP1 to the surface of P. falciparum-infected erythrocytes via a complex membrane network. Eur J Cell Biol (2003) 1.08
Illumination of the malaria parasite Plasmodium falciparum alters intracellular pH. Implications for live cell imaging. J Biol Chem (2002) 1.08
Quantitative calcium measurements in subcellular compartments of Plasmodium falciparum-infected erythrocytes. J Biol Chem (2005) 1.08
Genetic linkage analyses redefine the roles of PfCRT and PfMDR1 in drug accumulation and susceptibility in Plasmodium falciparum. Mol Microbiol (2011) 1.06
Maurer's cleft organization in the cytoplasm of plasmodium falciparum-infected erythrocytes: new insights from three-dimensional reconstruction of serial ultrathin sections. Eur J Cell Biol (2004) 1.06
IL-4 induces a wide-spectrum intracellular signaling cascade in CD8+ T cells. J Leukoc Biol (2007) 1.05
Memory CD8+ T cell responses expand when antigen presentation overcomes T cell self-regulation. J Immunol (2008) 1.04
Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites. Antimicrob Agents Chemother (2010) 1.03
Declining malaria parasite prevalence and trends of asymptomatic parasitaemia in a seasonal transmission setting in North-Western Burkina Faso between 2000 and 2009-2012. Malar J (2013) 1.03
Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and Mannich bases: interaction with DNA. J Med Chem (2010) 1.03
Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporter. Proc Natl Acad Sci U S A (2014) 1.01
Plasmodium vivax malaria in Mali: a study from three different regions. Malar J (2012) 1.01
Evidence for activation of endogenous transporters in Xenopus laevis oocytes expressing the Plasmodium falciparum chloroquine resistance transporter, PfCRT. J Biol Chem (2004) 1.00
Effector CD8+ T lymphocytes against liver stages of Plasmodium yoelii do not require gamma interferon for antiparasite activity. Infect Immun (2008) 0.99
Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum. Infect Immun (2013) 0.99
Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites. J Am Chem Soc (2011) 0.98
Direct activation of human endothelial cells by Plasmodium falciparum-infected erythrocytes. Infect Immun (2005) 0.98
Priming of CD8+ T cell responses following immunization with heat-killed Plasmodium sporozoites. Eur J Immunol (2006) 0.98
Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum. Mol Microbiol (2007) 0.98
Export of PfSBP1 to the Plasmodium falciparum Maurer's clefts. Traffic (2008) 0.98
Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria. J Immunol (2003) 0.96
Willingness to pay for hypothetical malaria vaccines in rural Burkina Faso. Scand J Public Health (2005) 0.96
A new computational approach redefines the subtelomeric vir superfamily of Plasmodium vivax. BMC Genomics (2013) 0.96
The skin: where malaria infection and the host immune response begin. Semin Immunopathol (2012) 0.95
Host actin remodeling and protection from malaria by hemoglobinopathies. Trends Parasitol (2012) 0.94
CD4+ T cells modulate expansion and survival but not functional properties of effector and memory CD8+ T cells induced by malaria sporozoites. PLoS One (2011) 0.94
A putative Sec23 homologue of Plasmodium falciparum is located in Maurer's clefts. Mol Biochem Parasitol (2003) 0.93
Spleen rupture in a case of untreated Plasmodium vivax infection. PLoS Negl Trop Dis (2012) 0.93
Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy. Infect Immun (2013) 0.93
Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice. Vaccine (2011) 0.92
The skin stage of malaria infection: biology and relevance to the malaria vaccine effort. Future Microbiol (2008) 0.92
Transient transfection of Plasmodium vivax blood stage parasites. Mol Biochem Parasitol (2006) 0.92
Regulation of the CD8+ T cell responses against Plasmodium liver stages in mice. Int J Parasitol (2004) 0.91
Nuclear run-on analysis of var gene expression in Plasmodium falciparum. Mol Biochem Parasitol (2007) 0.91
On cytoadhesion of Plasmodium vivax: raison d'être? Mem Inst Oswaldo Cruz (2011) 0.91
Recovery of adhesion to chondroitin-4-sulphate in Plasmodium falciparum varCSA disruption mutants by antigenically similar PfEMP1 variants. Mol Microbiol (2003) 0.91
Maternal malaria: Plasmodium falciparum sequestration in the placenta. Parasitol Res (2002) 0.91
Evaluation of the acquired immune responses to Plasmodium vivax VIR variant antigens in individuals living in malaria-endemic areas of Brazil. Malar J (2006) 0.90
Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays. Malar J (2011) 0.90
Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development. Mem Inst Oswaldo Cruz (2011) 0.90
Dissecting the components of quinine accumulation in Plasmodium falciparum. Mol Microbiol (2008) 0.89
Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum. J Med Chem (2008) 0.89
Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1. Antimicrob Agents Chemother (2006) 0.89
Computational and experimental analysis identified 6-diazo-5-oxonorleucine as a potential agent for treating infection by Plasmodium falciparum. Infect Genet Evol (2013) 0.89
CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives. Malar J (2010) 0.88
Trafficking of the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum. Traffic (2009) 0.88
A conditional export system provides new insights into protein export in Plasmodium falciparum-infected erythrocytes. Cell Microbiol (2008) 0.88
Mapping and characterization of the primary and anamnestic H-2(d)-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus. J Virol (2007) 0.88
CD8+ T cells eliminate liver-stage Plasmodium berghei parasites without detectable bystander effect. Infect Immun (2014) 0.88
Malaria vaccines: if at first you don't succeed... Trends Parasitol (2004) 0.87
Changing ideas on chloroquine in Plasmodium falciparum. Curr Opin Infect Dis (2000) 0.87
Sulfonyl-phenyl-ureido benzamidines; a novel structural class of potent antimalarial agents. Bioorg Med Chem Lett (2004) 0.87
Maurer's clefts--a novel secretory organelle? Mol Biochem Parasitol (2003) 0.87
PfCHA is a mitochondrial divalent cation/H+ antiporter in Plasmodium falciparum. Mol Microbiol (2010) 0.87
Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents. ChemMedChem (2013) 0.87
Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection. J Infect Dis (2007) 0.86
CpG-enhanced CD8+ T-cell responses to peptide immunization are severely inhibited by B cells. Eur J Immunol (2010) 0.86
Malaria in a holoendemic area of Burkina Faso: a cross-sectional study. Parasitol Res (2006) 0.85
Functional expression of ribozymes in Apicomplexa: towards exogenous control of gene expression by inducible RNA-cleavage. Int J Parasitol (2007) 0.85
T cell memory in malaria. Curr Opin Immunol (2007) 0.85
Anergy in memory CD4+ T cells is induced by B cells. J Immunol (2008) 0.83
Haemoglobin S and C affect the motion of Maurer's clefts in Plasmodium falciparum-infected erythrocytes. Cell Microbiol (2013) 0.83